Editorial: Novel modalities in cancer diagnostics and therapeutics
Front Pharmacol
.
2022 Nov 30:13:1101506.
doi: 10.3389/fphar.2022.1101506.
eCollection 2022.
Authors
Serena Li Zhao
1
,
Dong-Hua Yang
2
,
Haichang Li
3
4
Affiliations
1
Department of Medicinal Chemistry and Pharmacognosy, The Ohio State University College of Pharmacy, Columbus, OH, United States.
2
Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, New York, NY, United States.
3
Department of Surgery, The Ohio State University College of Medicine, Columbus, OH, United States.
4
Department of Veterinary Biosciences, The Ohio State University College of Veterinary Medicine, Columbus, OH, United States.
PMID:
36532765
PMCID:
PMC9748692
DOI:
10.3389/fphar.2022.1101506
No abstract available
Keywords:
cancer; diagnostics; novel modalities; technologies; therapeutics.
Publication types
Editorial